Peregrine Pharma & AstraZeneca expand ongoing immuno-oncology deal
Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, has expanded its ongoing cancer immunotherapy clinical collaboration with AstraZeneca, a global, innovation-driven biopharmaceutical business, to... Read More